General Session 2: Medical Prophylaxis and Therapy

VENOUS2025 Main Agenda

Treatment of superficial vein thrombosis with intermediate dose of tinzaparin in patients at high thromboembolic risk. Results from an observational, multicentre study.-The SeVEN Precision study

Speaker(s)

• 

  Christos Karathanos, MD, MSc, PhD

  Consultant of Vascular Surgery
  Deperment of Vascular Surgery, Univerisity General Hospital of Larisa, Larisa, Greece
  LARISA, Larisa, Greece

Co-Author(s)

• KN

  Konstantinos Nikolakopoulos

  Department of Vascular Surgery, University Hospital of Patras, Greece, Patra, Greece
  PATRA, Akhaia, Greece
• DC

  Dimitrios Chatzis

  Department of Vascular Surgery, University Hospital of Ioannina, Ioannina, Greece, Ioannina, Greece,
  Ioannina, Ioannina, Greece
• PL

  Panagiotis Latsios

  Private Vascular Surgeon, Kozani, Greece
  Kozani, Kozani, Greece
• IB

  Ioannis Bountouris

  Private Vascular surgeon, Athens, Greece, Athens, Greece
  Athens, Attiki, Greece
• DA

  Dimitrios Alexandropoulos

  Private Vascular surgeon, Patra, Greece, Patra, Greece
  PATRA, Akhaia, Greece
• AZ

  Aikaterini Karolina Zianika

  Department of Vascular Surgery, G.N.A ‘‘G. Gennimatas’’ Hospital, Athens, Greece, Athens, Greece,
  Athens, Attiki, Greece
• SK

  Stavros Kakkos

  Department of Vascular Surgery, University Hospital of Patras, Greece, Patra, Greece
  PATRA, Akhaia, Greece
• 

  Athanasios D. Giannoukas, MD, MSC, DTh,PhD, FEBS

  Professor of Vascular Surgery/Head, Vascular Surgery Dpt
  Department of Vascular Surgery, University Hospital of Larisa, Larisa, Greece
  Larisa, Larisa, Greece